Julie Fisher, MD

November 19, 2021

Patient Jocelyn Mueller and oncologist Julia Fisher, M.D., describe some of the adjustments that had to be made to Jocelyn’s treatment for HER2-positive breast cancer due to the COVID-19 pandemic.

November 12, 2021

Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.

November 12, 2021

Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.

November 05, 2021

Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.

November 05, 2021

Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.

October 29, 2021

Dr. Julie Fisher details the therapies used for HER2-positive breast cancer in the post-operative setting, including newly available treatment options, and reviews data supporting the choice of therapy for each patient.

October 29, 2021

Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.

October 22, 2021

Jocelyn Mueller, a patient with HER2-positive breast cancer, explains how she received her diagnosis.

October 22, 2021

Julie Fisher, MD, gives a brief overview of HER2-positive breast cancer and the tests available for diagnosis.